The National Agency for Food and Drug Administration and Control (NAFDAC) has launched an investigation into the death of National Youth Service Corps member Etimbuk Daniel at the NYSC orientation camp in Awgu, Enugu State, collecting samples of medications administered to him for laboratory analysis amid public concerns over the circumstances surrounding his death.
The agency disclosed that its officials had visited the camp clinic, interviewed medical personnel and other workers, and collected the drugs used in treating the deceased as part of efforts to establish whether the medications met the required safety and quality standards.
The investigation follows allegations that Daniel died after receiving substandard or falsified medicines at the orientation camp. However, NAFDAC has challenged claims that the medications caused his death, saying preliminary findings point to complications associated with severe dehydration and shock.
In a statement issued by its Director-General, Professor Mojisola Adeyeye, the agency said Daniel’s death required a careful examination of the medical circumstances surrounding his treatment rather than conclusions based on unverified allegations.
According to NAFDAC, Daniel was taken to the camp clinic by two fellow corps members at approximately 9pm on Wednesday, October 7, 2026, after developing symptoms suggestive of severe malaria. The agency also noted that he had a known history of peptic ulcer disease.
Medical personnel reportedly stabilised him with an intramuscular antimalarial drug and other supportive medications administered intravenously before placing him on bed rest for observation.
He was discharged with oral medications the following morning, Thursday, October 8, after his condition was assessed by the medical team.
However, Daniel returned to the clinic on Saturday, October 10, complaining of pain in his right thigh. NAFDAC said he arrived without assistance and was initially advised to see a physiotherapist.
His condition subsequently raised concern when the attending doctor noticed that he was sweating profusely. A blood pressure examination reportedly showed a reading of 80/40mmHg, indicating dangerously low blood pressure.
The medical team administered intravenous normal saline to stabilise him, but repeated monitoring showed that his blood pressure continued to fall.
According to the agency, his recurring hypotension, combined with poor urine output despite fluid resuscitation, prompted doctors to refer him to the University of Nigeria Teaching Hospital in Ituku-Ozalla, Enugu State.
Daniel was transported to the teaching hospital in an ambulance accompanied by a doctor. However, he reportedly slipped into a coma around the time he arrived, and attempts to resuscitate him were unsuccessful.
NAFDAC further disclosed that the camp clinic doctor was subsequently informed by one of Daniel’s friends that the corps member had been vomiting for two days after his initial admission. The agency said the doctor had not been aware of the vomiting before receiving that information.
The development has raised questions about the information available to the medical team during Daniel’s treatment and the extent to which his symptoms were communicated to healthcare personnel.
According to NAFDAC, the doctors believed that the cause of death was acute kidney injury resulting from severe dehydration and shock. However, the agency’s investigation remains ongoing, and its laboratory analysis is expected to provide further information about the medications administered to him.
In defending the drugs used at the camp clinic, NAFDAC stated that the same medications had been administered to several other patients who subsequently recovered.
The agency also noted that doctors, pharmacists and other healthcare workers at the clinic had prescribed and used the medications themselves at different times.
Nevertheless, the fact that other patients reportedly recovered does not, by itself, establish whether a particular medicine was safe in Daniel’s circumstances. The laboratory findings and a fuller examination of his medical history and treatment will be important in determining what happened.
The investigation has attracted wider attention because of Daniel’s background as a former student leader. He was the immediate past president of the Students’ Union Government of Akwa Ibom State University before embarking on the mandatory national service programme.
His death has also prompted intervention from the Nigerian Senate, which ordered a separate investigation into the circumstances surrounding the incident and the state of medical services at NYSC orientation camps nationwide.
The Senate’s decision followed a motion sponsored by Aniekan Bassey, senator representing Akwa Ibom North-East, who called for a review of healthcare provision and emergency response arrangements at orientation camps.
The legislative investigation is expected to examine concerns about medical infrastructure, access to qualified healthcare personnel and the procedures used to refer corps members requiring urgent medical attention to better-equipped hospitals.
The incident has renewed questions about the standard of healthcare available to young graduates during their orientation programme, particularly those who fall seriously ill while participating in camp activities.
Orientation camps accommodate large numbers of corps members who are temporarily away from their families and usual healthcare providers. Reliable medical services, effective monitoring and timely referral arrangements are therefore essential to protecting their welfare.
While NAFDAC’s investigation focuses on the quality and safety of the medicines administered to Daniel, the wider circumstances of his treatment also warrant careful scrutiny. Establishing whether the medications were compliant with regulatory standards is one aspect of the investigation; determining whether the symptoms were recognised and managed appropriately is another.
Both questions matter in understanding the circumstances of his death and identifying any measures needed to prevent similar incidents.
For now, NAFDAC has not announced the results of its laboratory analysis, and no final conclusion has been established regarding the role, if any, of the medications in Daniel’s death.
The agency has urged the public to remain calm while its investigation continues.
Daniel’s death has left his family, friends and former colleagues mourning the loss of a young man who had previously served as the leader of his university’s student union. The outcome of the investigations by NAFDAC and the Senate will be important in clarifying the circumstances surrounding the tragedy and determining whether further action is necessary.
As the inquiries proceed, attention will remain focused on the laboratory findings, the medical decisions made during Daniel’s treatment and the broader question of whether NYSC orientation camps have adequate healthcare arrangements to respond to medical emergencies.
The central issue remains unresolved: NAFDAC has begun testing the medications, but until the investigation produces its findings, claims that substandard drugs caused Daniel’s death cannot be treated as established fact.
